Home › Funds › Farallon Capital Management › PRME
Farallon Capital Management position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)1.24M sh
Reported value held$4.58M
Portfolio Weight0.02%
First reportedQ1 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 750.00K | $5.25M | New |
| Q2 2024 | 750.00K | $3.85M | Hold |
| Q3 2024 | 750.00K | $2.90M | Hold |
| Q4 2024 | 750.00K | $2.19M | Hold |
| Q1 2025 | 750.00K | $1.49M | Hold |
| Q2 2025 | 750.00K | $1.85M | Hold |
| Q3 2025 | 4.75M | $26.32M | Add |
| Q4 2025 | 1.24M | $4.31M | Reduce |
| Q1 2026 | 1.24M | $4.32M | Hold |
| Q2 2026 | 1.24M | $4.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Fidelity Management & Research (FMR) 1.76M sh · $6.50M · Q2 2026
- Two Sigma Investments 1.52M sh · $5.63M · Q2 2026